For Startups

Raising Capital for Your
Frontier Tech Startup?

If you're building breakthrough technology in longevity science or space economy, we want to hear from you.

GenSeed Capital invests €150K–€400K in pre-seed to Series A companies advancing human lifespan and expanding humanity's reach. We're currently building our pipeline for Q2 2026 first close.

Investment Focus

What We Invest In

We back deep-tech founders working at the frontier of longevity science and the space economy.

🧬

Longevity Science

  • Therapeutics extending healthy lifespan (senolytics, epigenetic reprogramming, NAD+ boosters)
  • Diagnostics and biomarkers for early disease detection
  • Precision medicine platforms and AI-driven drug discovery
  • Neurodegenerative disease interventions
  • Cardiovascular and metabolic health solutions
🚀

Space Economy

  • Launch systems and advanced propulsion technology
  • Satellite infrastructure, constellations, and ground systems
  • Earth observation and data analytics platforms
  • In-orbit services and manufacturing
  • Cislunar economy and lunar infrastructure
📍

Geographic Focus

  • Primary: EU member states (55%+ of portfolio)
  • Secondary: United Kingdom (15%)
  • Opportunistic: United States and global (30%)
  • Strong preference for companies with EU operations
💰

Investment Stage & Size

  • Pre-seed: €50K–€100K initial tickets
  • Seed: €150K–€250K initial tickets (our sweet spot)
  • Series A: €250K–€400K initial tickets
  • Follow-on capital reserved for top performers
Selection Criteria

What We Look For in Companies

Proprietary technology with defensible competitive moat
Founding team with deep domain expertise (PhD or 5+ years sector experience)
Addressable market >€1B within 10 years
Clear regulatory pathway (especially critical for biotech/aerospace)
Evidence of early traction: data, pilots, letters of intent, or revenue
Strong alignment with longevity or space economy thesis
Reasonable valuation relative to stage and traction
Potential for 10×+ return in success scenario (3–5× base case)
ESG and ethical research standards met
Institutional-quality business fundamentals and governance
Process

How It Works

01

Submit Application

Complete our startup application form below (10 minutes). We review all submissions.

02

Initial Review (1–2 weeks)

Our team reviews applications and responds to promising fits with next steps.

03

First Meeting (30 min)

Introductory video call to discuss your company, technology, traction, and fundraising.

04

Due Diligence (2–4 weeks)

Deep dive into technology, market opportunity, team background, financials, and cap table.

05

Investment Committee

Presentation to our investment committee for final decision and term sheet preparation.

06

Closing (2–3 weeks)

Legal documentation, KYC/AML compliance, and fund transfer. Welcome to the portfolio.

From application to term sheet typically takes 4–8 weeks for companies that pass initial screening.

Ready to raise capital or invest in
frontier technology?

Applications reviewed on a rolling basis • Responses within 2–3 weeks for promising fits

Questions? Email hello@genseed.vc

FAQ

Frequently Asked Questions